Interdisciplinary Toxicology's Cover Image

Interdisciplinary Toxicology

The Journal of Institute of Experimental Pharmacology of Slovak Academy of Sciences
Acceso abierto

Información de la revista
Descargar portada

Open Access Statement

The journal is an Open Access journal that allows a free unlimited access to all its contents without any restrictions upon publication to all users.

Open Access License

SCOPE

Interdisciplinary Toxicology (iTox) publishes quarterly and is devoted to the publication of research results in all areas of Toxicology and related scientific disciplines: /science/toxicology/itox/authors/scope/.
The primary mission of iTox is to assist Central and Eastern European researchers in communicating their achievements to the global scientific community, nevertheless, contributions from other regions of the world are by no means excluded. The journal is peer-reviewed, in electronic-only format. The language of the journal is English.

MANUSCRIPT SUBMISSION

Manuscripts preferred for publication in iTox are those which:

  • Contain original work - which is not published elsewhere in any medium by the authors or anyone else, and is not under consideration for publication in any other medium. This restriction does not apply to review articles.
  • Are focused on the core aims and scope of the journal - iTox is a scientific journal publishing fundamental research results from all fields of toxicology and related scientific disciplines.
  • Are clearly and correctly written - should contain all essential features of a complete scientific paper, should be written in a clear, easy to understand manner, and be readable for a wide audience.
  • Are written in English - should be clearly and grammatically written, in an easily readable style. Attention to detail of the language will avoid severe misunderstandings which might lead to rejection of the paper (Please note that authors who are not native-speakers of English can be provided with help in rewriting their contribution in correct English).
  • Are delivered in electronic format
    Manuscripts should be submitted via Electronic Manuscript Submission.

iTox publishes research articles, communications, review papers and book reviews.

a) Research Articles

b) Rapid Communications – short reports on new and exciting results of high urgency. Sending us a report of significant interest, authors are asked to provide an explanation in their cover letter describing in detail why their contribution should be handled via rapid channel

c) Reviews – topical mini(reviews) as well as full critical reviews on important subjects reflecting new trends in chemistry are also included in this section

d) Book reviews

PEER REVIEW PROCESS

All manuscripts sent via e-mail receive individual identification codes. The Managing Editor then sends it to an appropriate Editor. However a submission may be declined by the Managing Editor without review, if deemed inappropriate for reasons other than scientific merit.

a) choice of reviewers
The Editors of iTox, each responsible for different area of Toxicology, seek advice from experts of in the appropriate field. Research articles and communications are reviewed by a minimum of two reviewers, review papers by at least three.

b) suggestions from authors
Authors are requested to suggest persons competent to review their manuscript. However please note that this will be treated only as a suggestion, and the final selection of reviewers is exclusively the Editor’s decision.

The Editors are fully responsible for decisions about manuscripts. The final decision whether to accept or reject a paper rests with them. The Managing Editor only communicates the final decision, and informs the authors about further processing.
www.setox.eu/

REVISED MANUSCRIPT SUBMISSION

When revision of a manuscript is requested, authors should return the revised version of their manuscript as soon as possible. Prompt action may ensure fast publication if a paper is finally accepted for publication in iTox. If it is the first revision of an article authors need to return their revised manuscript within 60 days. If it is the second revision authors need to return their revised manuscript within 14 days. If these deadlines are not met, and no specific arrangements for completion have been made with the Editor, the manuscript will be treated as a new one and will receive a new identification code along with a new registration date.

FINAL PROOFREADING

Authors will receive a pdf file with the edited version of their manuscript for final proofreading. This is the last opportunity to view an article before its publication on the journal web site. No changes or modifications can be introduced once it is published. Thus authors are requested to check their proof pages carefully against manuscript within 3 working days and prepare a separate document containing all changes that should be introduced. Authors are sometimes asked to provide additional comments and explanations in response to remarks and queries from
the language or technical editors.

ONLINE FIRST SERVICE

Manuscripts accepted for publication are published on-line in so called Online First service as soon as they are ready for publication (that is when final proofreading is performed by authors, and all concerns are resolved). Final manuscripts for publication may appear on the Web 1-2 months prior to regular issue publication. Once a manuscript appears on the Web site it is considered as published.

REPRINTS

After publication, the corresponding author is notified by email, and receives a pdf file with the published version of the manuscript.

ERRATA

If any errors are detected in the published material they should be reported to the Managing Editor. The corresponding authors should send appropriate corrected material to the Managing Editor via email. This material will be considered for publication in the earliest available issue of iTox.

TRANSFER OF COPYRIGHT AGREEMENT

A properly completed Transfer of Copyright Agreement must be provided for each submitted manuscript. Transfer of Copyrights Agreement should be signed, scanned and sent via email to the Managing Editor of the journal. Please read the terms of this agreement, print and then fll, sign and send a scanned document by email to the Managing Editor of this journal.

eISSN:
1337-9569
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, Pharmacology, Toxicology